Overall, 14% of people with lung cancer survive for at least 5 years.
People who have stage I NSCLC and undergo lung surgery have a 60-70% chance of surviving 5 years.
People with stage II NSCLC have a 30-40% chance of cure, and those with stage IIIa have a 20-30% chance of cure.
People with extensive nonoperable lung cancer have an average survival duration of 9 months or less.
Those with limited SCLC who receive chemotherapy have a 2-year survival rate of 20-30% and a 5-year survival rate of 10-15%.
People with advanced SCLC have an average survival duration of 6-9 months. How well a person functions can have a strong effect on how long he or she survives. A person with SCLC who functions well has an advantage over a person who cannot work or pursue normal activities.
World Health Organization
Bronchodilators
Bronchodilators are medicines that help open the bronchial tubes (airways) of the lungs, allowing more air to flow through them.
Bronchoscopy allows a doctor to examine inside your airway for any abnormality such as foreign bodies, bleeding, a tumor, or inflammation. The doctor uses either a rigid bronchoscope or flexible bronchoscope.
Respiratory System, in anatomy and physiology, organs that deliver oxygen to the circulatory system for transport to all body cells. Oxygen is essential for cells, which use this vital substance to liberate the energy needed for cellular activities.
